North America Clinical Trial Supply & Logistics Market [2029]: Top Companies, Size, and Competitive Intelligence - TechSci Research
Comunicato Precedente
Comunicato Successivo
Introduction
According to a recent report by TechSci Research, titled "North America Clinical Trial Supply & Logistics Market – Industry Size, Share, Trends, Competition Forecast & Opportunities, 2029," the North America Clinical Trial Supply & Logistics Market was valued at USD 1.2 billion in 2023. The market is projected to grow at a compound annual growth rate (CAGR) of 6.81% during the forecast period from 2025 to 2029. This growth is driven by several key factors, including the increasing number of clinical trials in the region, advancements in biopharmaceutical research, and the adoption of digital technologies.
Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "North America Clinical Trial Supply & Logistics Market”
Market Drivers
Escalating Number of Clinical Trials
One of the primary drivers of the North America Clinical Trial Supply & Logistics market is the increasing number of clinical trials conducted in the region. The United States and Canada are at the forefront of pharmaceutical research and development, with numerous companies conducting clinical trials to bring new drugs and therapies to market. This surge in clinical trial activity directly translates into a heightened demand for reliable and streamlined supply chain services, encompassing packaging, labeling, storage, and distribution of investigational products.
Evolution of Biopharmaceutical Research
The continuous evolution of biopharmaceutical research is another pivotal factor propelling the demand for specialized clinical trial supply and logistics services. The industry is witnessing groundbreaking developments in areas such as genomics, precision medicine, and biologics. These advancements make clinical trials more complex and necessitate customized supply chain solutions, including temperature-controlled logistics for biologics and personalized medicines. This trend is reshaping the landscape of clinical trial logistics, focusing on ensuring the integrity and stability of sensitive investigational products.
Adoption of Digital Technologies
The development of digital technologies has been instrumental in overcoming the challenges encountered during clinical trials, especially during the COVID-19 pandemic. Digital services such as cloud-enabled digital cores, blockchain-based product tracking, and the Internet of Things (IoT) are transforming biopharmaceutical companies’ approach to medical supplies management. These technologies incorporate valuable insights from multiple data sources, improve patient experience, enhance trial productivity, and improve the quality of data collected in trials. For instance, in June 2020, Almac Clinical Technologies introduced Simplify, a next-generation Interactive Response Technology (IRT) solution designed to accelerate the study startup process.
Growing Research on Rare Diseases
The growing research on rare diseases is expected to drive the growth of the clinical trial supply and logistics market over the forecast period. Clinical trials focused on rare diseases are on the rise, and many of these conditions have specific supply chain challenges due to limited patient populations and specialized treatments. Rare diseases, often chronic, severely disabling, and sometimes fatal, affect fewer than one in 2,000 persons in Canada and fewer than 200,000 persons in the United States. The specialized nature of treatments for these diseases necessitates robust and efficient supply chain solutions.
Increased R&D Investment and Facility Expansion
There has been a significant increase in research and development (R&D) investment and facility expansion by pharmaceutical and biotechnology firms aiming for the approval and launch of new drugs. High investments in R&D and adequate supply and logistical facilities increase the likelihood of successful drug development. For example, in July 2022, DHL Freight expanded its network in Germany by acquiring a new terminal in Mettmann, close to Düsseldorf, enhancing its capacity for clinical trial logistics.
Market Segmentation
The North America Clinical Trial Supply & Logistics Market is segmented into Service, Therapeutic Area, Phase, Country Distribution, and Company.
Phase III Dominance
Based on the Phase, Phase III emerged as the dominant segment in the North America Clinical Trial Supply & Logistics Market in 2023. Phase III trials are characterized by their large scale, involving a substantial number of participants across multiple sites, often conducted internationally. The complexity of these trials, which may include diverse patient populations, various geographic locations, and rigorous study designs, necessitates sophisticated supply chain and logistics solutions. The sheer scale and intricacy of Phase III trials amplify the demand for efficient and reliable clinical trial supply services.
Country Distribution
Canada emerged as the fastest-growing country in the North America Clinical Trial Supply & Logistics Market in 2023. The country boasts a robust healthcare system and well-established research infrastructure, including world-class hospitals, research institutions, and universities. This infrastructure facilitates efficient clinical trial operations, from participant recruitment to the delivery of trial supplies. Increased investment in healthcare and pharmaceutical research, coupled with a culture of innovation, has contributed to the growth of the clinical trial sector in Canada. The country's multicultural society provides access to a diverse patient population, essential for conducting comprehensive clinical trials that represent different demographic groups.
Recent Trends
Digital Transformation
The integration of digital technologies in clinical trial logistics is a significant trend shaping the industry. Innovations such as blockchain for secure and transparent tracking, cloud computing for efficient data management, and IoT for real-time monitoring of supply chain activities are enhancing the efficiency and reliability of clinical trial logistics. These technologies are not only improving operational efficiency but also ensuring compliance with stringent regulatory requirements.
Precision Medicine and Biologics
The growing focus on precision medicine and biologics is driving the demand for specialized logistics solutions. Precision medicine requires tailored treatments based on individual genetic profiles, necessitating highly specialized and controlled supply chains. Similarly, biologics, which are sensitive to temperature and environmental conditions, require robust and sophisticated logistics solutions to maintain their efficacy and safety throughout the supply chain.
Increasing Collaboration and Partnerships
Collaborations and partnerships among pharmaceutical companies, logistics providers, and technology firms are becoming increasingly common. These collaborations aim to leverage each party's expertise to enhance the efficiency and effectiveness of clinical trial logistics. For instance, the acquisition of Bomi Group by UPS in August 2022 aimed to enhance UPS's healthcare logistics capabilities by adding temperature-controlled facilities in 14 countries, thus improving global healthcare logistics capabilities.
Competitive Analysis
The North America Clinical Trial Supply & Logistics Market is highly competitive, with several major companies operating in the space. Key players in the market include:
- Thermo Fisher Scientific Inc.
- Catalent, Inc.
- Parexel International (MA) Corporation
- Almac Group Inc.
- Marken LLC
- Piramal Pharma Solutions
- Evoke Health LLC
- DHL International Ltd
- FedEx Corporation
- Packaging Coordinators Inc.
Competitive Strategies
These companies are employing various strategies to maintain and enhance their market positions. These strategies include:
- Acquisitions and Mergers: Companies are acquiring or merging with other firms to expand their capabilities and market reach. For example, the acquisition of COLCA-MS by Petrone Group in February 2023 aimed to develop tailored supply chain solutions for pharmaceutical companies working with rare and orphan diseases.
- Technological Advancements: Investment in digital technologies to improve operational efficiency and ensure compliance with regulatory requirements is a common strategy. Cloudbyz's introduction of Cloudbyz EDC 2.0 in March 2023 is an example of leveraging technology to enhance clinical trial data management.
- Geographic Expansion: Expanding operations to new regions to tap into growing markets. DHL Freight's expansion in Germany is an example of geographic expansion to enhance logistical capabilities.
Benefits of the Research Report
The TechSci Research report on the North America Clinical Trial Supply & Logistics Market provides several benefits, including:
- Comprehensive Market Insights: In-depth analysis of market size, share, and growth trends.
- Market Drivers and Restraints: Detailed understanding of the factors driving and restraining market growth.
- Segmentation Analysis: Insights into different market segments and their performance.
- Competitive Landscape: Analysis of key players and their strategies.
- Technological Trends: Overview of the latest technological advancements in the market.
- Regulatory Insights: Information on regulatory requirements and their impact on the market.
- Investment Opportunities: Identification of potential investment opportunities.
- Market Forecast: Projections of market growth over the forecast period.
- Strategic Recommendations: Actionable recommendations for market participants.
- Industry Best Practices: Insights into best practices for clinical trial logistics.
The North America Clinical Trial Supply & Logistics Market is poised for significant growth, driven by the increasing number of clinical trials, advancements in biopharmaceutical research, and the adoption of digital technologies. The market is characterized by its complexity, necessitating sophisticated and reliable supply chain solutions. The growing focus on precision medicine and biologics further underscores the need for specialized logistics services. With continued investments in R&D and the expansion of logistical facilities, the market is expected to witness robust growth in the coming years. The competitive landscape is dynamic, with key players employing various strategies to enhance their market positions and capitalize on emerging opportunities.
Customers can also request for 10% free customization on this report
Recently Published Report –
Animal Intestinal Health Market
Respiratory Diagnostics Market
Blog: Top 5 Challenges Petrochemical Industry Will Face in 2024
Contact
US -
Techsci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +13322586602
Email: [email protected]
